Showing results (81-90 of 2,459) with videos related to
Sort By:
Pageof 246
Biostatistics (Oxford, England)|July 2, 2013
Case-only method for cause-specific hazards models with application to assessing differential vaccine efficacy by viral and host geneticsJames Y Dai, Shuying S Li, Peter B GilbertJournal of the American Statistical Association|November 5, 2013
Sensitivity Analysis of Per-Protocol Time-to-Event Treatment Efficacy in Randomized Clinical TrialsPeter B Gilbert, Bryan E Shepherd, Michael G HudgensBiostatistics (Oxford, England)|September 22, 2016
Statistical methods for down-selection of treatment regimens based on multiple endpoints, with application to HIV vaccine trialsYing Huang, Peter B Gilbert, Rong Fu, et al.Lifetime Data Analysis|April 11, 2020
Analysis of the time-varying Cox model for the cause-specific hazard functions with missing causesFei Heng, Yanqing Sun, Seunggeun Hyun, et al.Statistics in Medicine|October 30, 2014
Comparing and combining biomarkers as principal surrogates for time-to-event clinical endpointsErin E Gabriel, Michael C Sachs, Peter B GilbertBiometrical Journal. Biometrische Zeitschrift|March 1, 2018
Hypothesis tests for stratified mark-specific proportional hazards models with missing covariates, with application to HIV vaccine efficacy trialsYanqing Sun, Li Qi, Guangren Yang, et al.Journal of the Royal Statistical Society. Series C, Applied Statistics|November 16, 2020
A Hybrid Approach for the Stratified Mark-Specific Proportional Hazards Model with Missing Covariates and Missing Marks, with Application to Vaccine Efficacy TrialsYanqing Sun, Li Qi, Fei Heng, et al.Journal of the American Statistical Association|August 26, 2024
Inference for treatment-specific survival curves using machine learningTed Westling, Alex Luedtke, Peter B Gilbert, et al.Biometrics|November 21, 2025
Generalized nonparametric temporal modeling of recurrent events with application to a malaria vaccine trialFei Heng, Yanqing Sun, Jing Xu, et al.American Journal of Epidemiology|January 24, 2020
Designing a Study of Correlates of Risk for Ebola VaccinationM Elizabeth Halloran, Ira M Longini, Peter B GilbertPageof 246